Search research articles
Contact Us
Filters
Showing results (131-140 of 218) with videos related to
Page
of 22
Sort By:
Clinical Physiology (Oxford, England)
|
March 1, 1994
Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure
B Ullman, K Lindvall, J M Lundberg, et al.
International Journal of Cardiology
|
January 3, 2014
Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006
L G Olsson, K Swedberg, G Lappas, et al.
Blood Pressure
|
April 21, 2017
Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme
K Swedberg, M Pfeffer, G B Granger, et al.
European Heart Journal
|
June 1, 1997
Skeletal muscle alterations in patients with chronic heart failure
M Schaufelberger, B O Eriksson, G Grimby, et al.
Journal of the American College of Cardiology
|
February 17, 2000
The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators
K Swedberg, C H Bergh, K Dickstein, et al.
Journal of the American College of Cardiology
|
November 15, 1995
Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina
M Dellborg, K Malmberg, L Rydén, et al.
Clinical Cardiology
|
November 1, 1994
Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
S V Eriksson, P Eneroth, J Kjekshus, et al.
The New England Journal of Medicine
|
September 3, 1992
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
K Swedberg, P Held, J Kjekshus, et al.
British Heart Journal
|
November 1, 1994
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group
A Sigurdsson, O Amtorp, T Gundersen, et al.
International Journal of Sports Medicine
|
April 2, 2003
Heart failure in an elite soccer player
M A Börjesson, R Rosengren, M Aunes-Jansson, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 218) with videos related to
Sort By:
Page
of 22
Clinical Physiology (Oxford, England)
|
March 1, 1994
Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure
B Ullman, K Lindvall, J M Lundberg, et al.
International Journal of Cardiology
|
January 3, 2014
Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006
L G Olsson, K Swedberg, G Lappas, et al.
Blood Pressure
|
April 21, 2017
Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme
K Swedberg, M Pfeffer, G B Granger, et al.
European Heart Journal
|
June 1, 1997
Skeletal muscle alterations in patients with chronic heart failure
M Schaufelberger, B O Eriksson, G Grimby, et al.
Journal of the American College of Cardiology
|
February 17, 2000
The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators
K Swedberg, C H Bergh, K Dickstein, et al.
Journal of the American College of Cardiology
|
November 15, 1995
Dynamic on-line vectorcardiography improves and simplifies in-hospital ischemia monitoring of patients with unstable angina
M Dellborg, K Malmberg, L Rydén, et al.
Clinical Cardiology
|
November 1, 1994
Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
S V Eriksson, P Eneroth, J Kjekshus, et al.
The New England Journal of Medicine
|
September 3, 1992
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
K Swedberg, P Held, J Kjekshus, et al.
British Heart Journal
|
November 1, 1994
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group
A Sigurdsson, O Amtorp, T Gundersen, et al.
International Journal of Sports Medicine
|
April 2, 2003
Heart failure in an elite soccer player
M A Börjesson, R Rosengren, M Aunes-Jansson, et al.
Page
of 22